Reuters
Health
FDA staff question side effects of Regeneron gout drug
Fri, May 04 09:52 AM EDT

By Anna Yukhananov

WASHINGTON (Reuters) - U.S. drug reviewers said Regeneron Pharmaceuticals Inc's drug to prevent gout flares worked, but questioned its side effects and whether it did enough to help patients.


Full Article   (Pic)
Next Article in Health